News|Articles|May 31, 2024

Gene Expression Assays

Experience flexibility with TaqMan assays, offering over 2.8 million predesigned options to meet your specific needs.

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Related Content

Executive Summary: Supporting mRNA Development With Quantitative Expression Analysis

BySCIEX

October 23rd 2025

Applying Analytical Quality by Design Principles to Biopharma Method Development and Optimization

ByWaters

October 21st 2025

Executive Summary: Mastering Nitrosamines Analysis With Streamlined LC-MS/MS Solutions

BySCIEX

October 21st 2025

Celebrating 20 Years of HPLC-CAD Technology

ByThermo Fisher Scientific

October 10th 2025

Streamline AAV-based Gene Therapies with High-Performing Off-the-Shelf Plasmids

ByCatalent

October 9th 2025

Gene Expression Assays

Newsletter

Related Content

Executive Summary: Supporting mRNA Development With Quantitative Expression Analysis

Applying Analytical Quality by Design Principles to Biopharma Method Development and Optimization

Executive Summary: Mastering Nitrosamines Analysis With Streamlined LC-MS/MS Solutions

Celebrating 20 Years of HPLC-CAD Technology

Streamline AAV-based Gene Therapies with High-Performing Off-the-Shelf Plasmids

Trending on BioPharm International

A-TEEM: A Novel, Powerful Tool for Evaluating and Monitoring Cell Culture Media

Challenges, Innovations, and Future Outlook of Biologics Formulations

Behind the Headlines Episode 27: Unpacking Mega Deals and R&D Directions

CPHI Frankfurt 2025 Highlights Global Pharma Innovation and Manufacturing Leadership

Global Study Confirms Survival Advantage of Mogamulizumab in Advanced Mycosis Fungoides and Sézary Syndrome